Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial

被引：0
|
作者：
Rubhana Raqib
Protim Sarker
Akhirunnesa Mily
Nur Haque Alam
Abu Saleh Mohammed Arifuzzaman
Rokeya Sultana Rekha
Jan Andersson
Gudmundur H Gudmundsson
Alejandro Cravioto
Birgitta Agerberth
机构：
[1] International Centre for Diarrheal Disease Research,Department of Medical Biochemistry and Biophysics
[2] Karolinska Institutet,Center for Infectious Medicine, Department of Medicine
[3] Karolinska University Hospital Huddinge,Institute of Biology
[4] University of Iceland,Nutritional Biochemistry Laboratory, Laboratory Sciences Division
[5] International Centre for Diarrheal Disease Research,undefined
[6] Bangladesh (icddr,undefined
[7] b),undefined
来源：
BMC Infectious Diseases | / 12卷
关键词：
Short chain fatty acids; Butyrate; Shigellosis; Innate immunity; Antimicrobial peptides; Cathelicidin; LL-37; Inflammation; Pro-inflammatory cytokines; Rectal mucosa;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial
    Raqib, Rubhana
    Sarker, Protim
    Mily, Akhirunnesa
    Alam, Nur Haque
    Arifuzzaman, Abu Saleh Mohammed
    Rekha, Rokeya Sultana
    Andersson, Jan
    Gudmundsson, Gudmundur H.
    Cravioto, Alejandro
    Agerberth, Birgitta
    [J]. BMC INFECTIOUS DISEASES, 2012, 12
  • [2] Simvastatin adjunct therapy for negative symptoms of schizophrenia: a randomized double-blind placebo-controlled trial
    Tajik-Esmaeeli, Soode
    Moazen-Zadeh, Ehsan
    Abbasi, Niloofar
    Shariat, Seyed V.
    Rezaei, Farzin
    Salehi, Bahman
    Akhondzadeh, Shahin
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2017, 32 (02) : 87 - 94
  • [3] Divalproex sodium in alcohol withdrawal: A randomized double-blind placebo-controlled clinical trial
    Reoux, JP
    Saxon, AJ
    Malte, CA
    Baer, JS
    Sloan, KL
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2001, 25 (09) : 1324 - 1329
  • [4] Safety and Efficacy of Levamisole in Loiasis: A Randomized, Placebo-controlled, Double-blind Clinical Trial
    Campillo, Jeremy T.
    Bikita, Paul
    Hemilembolo, Marlhand
    Louya, Frederic
    Missamou, Francois
    Pion, Sebastien D. S.
    Boussinesq, Michel
    Chesnais, CedricB
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : 19 - 27
  • [5] Pregnenolone as an adjunct to risperidone for treatment of women with schizophrenia: A randomized double-blind placebo-controlled clinical trial
    Kashani, Ladan
    Shams, Nazila
    Moazen-Zadeh, Ehsan
    Karkhaneh-Yousefi, Mohammad-Ali
    Sadighi, Gita
    Khodaie-Ardakani, Mohammad-Reza
    Rezaei, Farzin
    Rahiminejad, Fatemeh
    Akhondzadeh, Shahin
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2017, 94 : 70 - 77
  • [6] Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial
    Moghaddam, Hossein Sanjari
    Bahmani, Soya
    Bayanati, Samaneh
    Mahdavinasa, Mahsa
    Rezaei, Farzin
    Akhondzadeh, Shahin
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2020, 35 (02) : 81 - 88
  • [7] Efficacy of extracorporeal shockwave therapy in patients with lateral epicondylitis: A randomized, placebo-controlled, double-blind clinical trial
    Guler, Nilgun Senol
    Sargin, Serdar
    Sahin, Nilay
    [J]. NORTHERN CLINICS OF ISTANBUL, 2018, 5 (04) : 314 - 318
  • [8] Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
    Karbalaee, Monire
    Jameie, Melika
    Amanollahi, Mobina
    TaghaviZanjani, Fateme
    Parsaei, Mohammadamin
    Basti, Fatemeh A.
    Mokhtari, Saba
    Moradi, Kamyar
    Akhondzadeh, Shahin
    [J]. SCHIZOPHRENIA RESEARCH, 2023, 254 : 92 - 98
  • [9] Efficacy of spironolactone as adjunctive therapy to sodium valproate in bipolar-I disorder: A double-blind, randomized, placebo-controlled clinical trial
    Zandifar, Atefeh
    Badrfam, Rahim
    Gholamian, Fatemeh
    Shafiee, Arman
    [J]. BRAIN AND BEHAVIOR, 2023, 13 (12):
  • [10] OXCARBAZEPINE AS AN ADJUNCT OF ANTIPSYCHOTIC THERAPY IN ACUTE SCHIZOPHRENIA: A DOUBLE-BLIND, RANDOMISED PLACEBO-CONTROLLED CLINICAL TRIAL
    Koethe, D.
    Kranaster, L.
    Hellmich, M.
    Nolden, B. M.
    Klosterkoetter, J.
    [J]. EUROPEAN PSYCHIATRY, 2009, 24
12345